Research Article

Suspected Spontaneous Reports of Birth Defects in the UK Associated with the Use of Carbimazole and Propylthiouracil in Pregnancy

Table 1

Suspected adverse drug reactions of congenital anomalies associated with carbimazole and propylthiouracil received via the UK Yellow Card Scheme.

CarbimazolePropylthiouracil
SystemCongenital anomalies*Number of anomalies (total)Number with single anomalyNumber with other anomaliesNumber of anomalies (total)Number with single anomalyNumber
with other
anomalies

SkinAplasia cutis624000
Other (skin disorder, ulcer)202000

RespiratoryChoanal atresia523000
Tracheo-oesophageal fistula220000
Other (neonatal respiratory distress syndrome, respiratory disorder)202000

GastrointestinalCleft palate532110
Omphalocele/umbilical abnormalities422202
Patent vitellointestinal duct101000
Duodenal atresia110000
Anal atresia101000
Other (neonatal jaundice and abnormal liver function tests)202000
Not specified321000

CardiovascularSeptal defects312000
Other (Fallot’s tetralogy and coarctation of aorta)220000
Not specified101000

MusculoskeletalLimb/hand/foot malformation413312
Not specified431000

NeurologicalSpina bifida312000
Hydrocephalus514000
Anencephaly440101
Hypotonia202000
Other (spine malformation and holoprosencephaly)101101

Renal/urinary tractRenal aplasia101000
Other (urinary tract malformation, epispadias)101110

EndocrineThyroid disorder101000
Hypogonadism101000

CraniofacialDysmorphic facies202101
Skull malformation413000
Ear malformation312000
Deafness422000
Eye malformation413000
Other (nose malformation and teeth malformation)202000

OthersNipple/breast anomalies (athelia and hypoplastic nipples)202000
Developmental delay202000
Autism000101
Not specified716000

Total9733641138

*One Yellow Card report may contain more than one reaction term. Therefore, the total number of reactions is greater than the total number of reports.